$TLSI insider trading
Over the last 12 months, TriSalus Life Sciences insiders reported 6 buys totaling $1.8M and 8 sales totaling $138K across SEC Form 4 filings.
- Bought · 12m
- $1.8M 6 events
- Sold · 12m
- $138K 8 events
- Events · 12m
- 14 Form 4 filings, grouped
- Insiders · 12m
- 9 distinct reporters
- 10b5-1 share
- 0% of events, not dollars
All insider trades
Scroll the table sideways for price, value and marks.
| Date | Insider | Type | Shares | Avg price | Value | Δ stake | Marks |
|---|---|---|---|---|---|---|---|
| Oct 5, 2026 | Cox Bryan F.Chief of Research · O | ▼ Sale | 296 | $4.39 | $1K | -0.2% | — |
| Oct 5, 2026 | Marshak RichardChief Commercial Officer · O | ▼ Sale | 325 | $4.39 | $1K | -0.3% | — |
| Oct 5, 2026 | Stevens JenniferChief Regulatory Officer · O | ▼ Sale | 316 | $4.39 | $1K | -0.3% | — |
| Mar 17, 2026 | Szela Mary TCEO and President · O·D | ▼ Sale | 20,302 | $3.91 | $79K | -2.6% | 2 tranches |
| Mar 16, 2026 | Devlin JodiChief of Clinical Operations · O | ▼ Sale | 3,207 | $4.11 | $13K | -3.2% | late · 3 tranches |
| Mar 16, 2026 | Cox Bryan F.Chief of Research · O | ▼ Sale | 3,184 | $4.11 | $13K | -1.9% | late · 3 tranches |
| Mar 16, 2026 | Marshak RichardChief Commercial Officer · O | ▼ Sale | 3,457 | $4.11 | $14K | -3% | late · 3 tranches |
| Mar 16, 2026 | Stevens JenniferChief Regulatory Officer · O | ▼ Sale | 3,530 | $4.11 | $15K | -2.8% | late · 3 tranches |
| Feb 23, 2026 | Patience DavidChief Financial Officer · O | ▲ Buy | 3,657 | $4.1 | $15K | +1.4% | — |
| Feb 23, 2026 | Gordon Gary B.D | ▲ Buy | 9,756 | $4.1 | $40K | — | — |
| Feb 23, 2026 | Valle WilliamD | ▲ Buy | 30,487 | $4.1 | $125K | — | — |
| Feb 23, 2026 | Szela Mary TCEO and President · O·D | ▲ Buy | 30,487 | $4.1 | $125K | +4.1% | — |
| Feb 23, 2026 | Stansky Michael PD | ▲ Buy | 117,198 | $4.1 | $481K | +142.1% | indirect |
| Feb 23, 2026 | Stansky Michael PD | ▲ Buy | 243,900 | $4.1 | $1000K | +44.9% | — |
Every $TLSI filing on this page is one API call away
The same Form 4 data over REST or MCP, already grouped into events with the plan flag and the dollar value read. A free key does 100 calls a day and needs no card. Prefer email? TriSalus Life Sciences filings can reach your inbox instead.
Corporate insiders — officers, directors and 10%+ owners — must report their trades to the SEC on Form 4 within two business days. This page shows open-market activity: purchases (code P), sales (S) and dispositions back to the issuer (D). Scheduled compensation events such as stock grants and option exercises are also filed on Form 4 but carry no trading signal, so they are not shown and counts here can be lower than the raw EDGAR filing total. We group each filing's transactions into one economic event (a laddered 10b5-1 sale is one event, not 25 rows), flag pre-arranged plans and late filings, and link every event to its AI-scored article in the $TLSI feed.